Cencora, Inc. (COR)
(Delayed Data from NYSE)
$222.00 USD
-0.42 (-0.19%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $222.04 +0.04 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
COR 222.00 -0.42(-0.19%)
Will COR be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for COR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COR
Why Cencora (COR) is Poised to Beat Earnings Estimates Again
Cencora (COR) Stock Nosedives: Here's What Caused the Decline
COR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
Other News for COR
Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
Buy Rating on Cencora’s Stock Amidst Walgreens Store Closures: Assessing Minimal EBIT Impact and Market Overreaction
Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
The legal odyssey for OxyContin maker Purdue Pharma and its owners is complex. Here's what to know